The tear and plasma pharmacokinetics study of TS-1 monotherapy for gastric cancer patients.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Pharmacokinetics
- 27 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 27 Jun 2016 Status changed from not yet recruiting to recruiting.
- 27 May 2016 New trial record